Table 2 Observed and Weighted EQ-5D-5L Assessments with Comparisons with US Population Norms
From: Assessment of retrospective collection of EQ-5D-5L in a US COVID-19 population
n | UI | EQ VAS | Percent with problem | |||||
|---|---|---|---|---|---|---|---|---|
MO | SC | UC | PD | AD | ||||
Pre-COVID-19 | ||||||||
Observed | 676 | 0.924 (0.117) | 87.4 (10.9) | 7.3 | 2.7 | 7.6 | 27.8 | 43.5 |
MAIC 1 | 440 a | 0.922 (0.125) | 87.0 (10.8) | 8.9 | 3.1 | 8.2 | 27.6 | 41.0 |
MAIC 2 | 291 a | 0.866 (0.176) | 84.6 (12.8) | 28.4 | 9.0 | 16.6 | 40.9 | 47.4 |
COVID-19 | ||||||||
Observed | 671 | 0.808 (0.204) | 73.3 (16.9) | 17.2 | 11.4 | 51.3 | 67.3 | 53.7 |
MAIC 1 | 440 a | 0.820 (0.192) | 74.3 (16.8) | 19.0 | 10.4 | 47.9 | 63.5 | 50.6 |
Jiang et al. (2021) (12) | 1,134 | 0.851 (0.205) | 80.4 (15.6) | 28.4 | 6.5 | 24.7 | 51.0 | 38.4 |
Cha et al. (2019) (16) b | 1,047 | Not available | 84.6 (14.5) | 25.2 | 6.9 | 21.8 | 40.1 | 29.6 |